Join the Alliance

Events

Nanomedicines Alliance Session at 2nd FDA/PQRI Conference on Advancing Product Quality

On 5 October 2015, the Nanomedicines Alliance will co-lead the panel session Current Challenges in the Characterization of Complex Drug Formulations Containing Nanomaterials with FDA at the 2nd FDA/PQRI Conference on Advancing Product Quality in Bethesda, MD.


View the complete conference program here and click here to register.


Nanomedicines: Charting a Roadmap to Commercialization

On 6-7 March 2013, the Nanomedicines Alliance held an Industry Symposium: Charting a Road to Commercialization. A white paper on the Symposium, Nanomedicine Drug Development: A Scientific Symposium Entitled Charting a Roadmap to Commercialization, has been published in the AAPS Journal.


The Symposium addressed: